- Home
- BLBD vs BCRX Comparison
BLBD vs BCRX Comparison
Compare BLBD & BCRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | BLBD | BCRX |
|---|---|---|
| Founded | 1927 | 1986 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Construction/Ag Equipment/Trucks | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.7B | 1.6B |
| IPO Year | N/A | 1994 |
Fundamental Metrics
Financial Performance| Metric | BLBD | BCRX |
|---|---|---|
| Price | $55.71 | $6.71 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 5 | 11 |
| Target Price | ★ $67.20 | $20.82 |
| AVG Volume (30 Days) | 533.3K | ★ 4.6M |
| Earning Date | 02-04-2026 | 02-26-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 23.43 | N/A |
| EPS | ★ 3.96 | N/A |
| Revenue | ★ $1,499,311,000.00 | $599,816,000.00 |
| Revenue This Year | $4.86 | $40.21 |
| Revenue Next Year | $3.41 | $6.13 |
| P/E Ratio | $14.58 | ★ N/A |
| Revenue Growth | 11.61 | ★ 45.38 |
| 52 Week Low | $30.04 | $6.00 |
| 52 Week High | $61.95 | $11.31 |
Technical Indicators
Market Signals| Indicator | BLBD | BCRX |
|---|---|---|
| Relative Strength Index (RSI) | 59.40 | 48.88 |
| Support Level | $56.03 | $6.26 |
| Resistance Level | $59.92 | $6.91 |
| Average True Range (ATR) | 2.39 | 0.28 |
| MACD | 0.70 | 0.04 |
| Stochastic Oscillator | 62.62 | 61.31 |
Price Performance
Historical ComparisonAbout BLBD Blue Bird Corporation
Blue Bird Corp is an American bus manufacturing company. It is an independent designer and manufacturer of school buses. The company operates in two segments; the Bus segment which involves the design, engineering, manufacture, and sales of school buses and extended warranties; and the Parts segment which includes the sales of replacement bus parts. Geographically, the company generates a majority of its revenue from its customers in the United States and the rest from Canada and Rest of the world.
About BCRX BioCryst Pharmaceuticals Inc.
BioCryst Pharmaceuticals Inc is a biotechnology company involved mainly in the research and development of novel small-molecule drugs, to block key enzymes involved in infectious and inflammatory diseases. Biocryst's research is based on multiple scientific disciplines like biology, computer modeling, and medicinal chemistry. Its products and candidates target the following therapeutic areas: acute uncomplicated influenza; uncomplicated seasonal influenza; hereditary angioedema; filoviruses, including the Ebola and Marburg viruses; and oncology.